New Breakthrough in Parkinson’s Disease Treatment Research

New Breakthrough in Parkinson’s Disease Treatment Research

In recent years, research into treatments for Parkinson’s disease has made significant progress. Recently, a new research breakthrough promises to provide remarkable results in long-term treatment without generating side effects. The research, led by Aarhus University and published in the journal Nature Communications on Tuesday, has developed an innovative method that ensures a much higher … Read more

Rutgers University Studies Make Remarkable Advances in Female Fertility Research

Rutgers University Studies Make Remarkable Advances in Female Fertility Research

Two studies conducted by the American Rutgers University have made remarkable advances in female fertility research, bringing to the world essential information about the success and failure of eggs to form embryos that lead to pregnancy and birth. Researchers investigating the problems of miscarriages aimed to identify a way to predict whether an egg will … Read more

EMA Committee Recommends Authorization of GSK’s Momelotinib for Myelofibrosis Treatment in EU

EMA Committee Recommends Authorization of GSK’s Momelotinib for Myelofibrosis Treatment in EU

The European Medicines Agency (EMA) committee has recommended the authorization of GlaxoSmithKline’s (GSK) oral therapy to treat myelofibrosis, a rare type of blood cancer that affects the bone marrow. The announcement was made by GSK on a Monday. This oral therapy offers a possible new treatment alternative for patients diagnosed with myelofibrosis in the European … Read more

Label-Free 3D Structures as Biomarkers for Sepsis: A Promising Option for Rapid Monitoring

Label-Free 3D Structures as Biomarkers for Sepsis: A Promising Option for Rapid Monitoring

Sepsis is a serious condition with high mortality rates due to the highly variable and complex immune response. Early detection and immediate intervention are essential, which is why the scientific community is actively searching for new biomarkers that can provide rapid and reliable monitoring of patients affected by sepsis. Current biomarkers, such as CRP and … Read more

World’s First Total Eye Transplant in Living Person at NYU Langone Hospital

World’s First Total Eye Transplant in Living Person at NYU Langone Hospital

A team of surgeons at NYU Langone Hospital in New York has announced that they have performed the world’s first total eye transplant in a living person. The patient, a man from Arkansas, lost his left eye and part of his face in a work accident. The patient, a 46-year-old military veteran, suffered an electrocution … Read more

Scientific Breakthrough: Birth of the First Chimeric Monkey Using Stem Cells

Scientific Breakthrough: Birth of the First Chimeric Monkey Using Stem Cells

A team of researchers in China has announced the birth of a living monkey that contains a significant proportion of cells derived from a monkey stem cell line, marking a scientific first. The newborn, a male monkey, was the result of a remarkable experiment in which pluripotent stem cells from two genetically distinct fertilized eggs … Read more

Innovative Method for Producing Stronger Immune Cells for Cancer Therapy

Innovative Method for Producing Stronger Immune Cells for Cancer Therapy

A group of researchers in the United States has developed an innovative method to produce stronger immune cells, able to be stored and used in the future in cell therapies to fight difficult forms of cancer. Specialists from UCLA in the United States have found a new method to create gamma delta T immune cells … Read more

Promising New Blood Cancer Treatment Shows Impressive Results in Clinical Trial

Promising New Blood Cancer Treatment Shows Impressive Results in Clinical Trial

Blood cancer is a deadly disease that kills one every nine minutes in the United States and diagnoses one every three minutes. This form of cancer focuses on white blood cells called B lymphocytes, which are essential in making antibodies and fighting infection. Chronic lymphocytic leukemia (CLL) is the most common form of leukemia, accounting … Read more

University of Pennsylvania’s Breakthrough Treatment for Recurrent Breast Cancer

University of Pennsylvania’s Breakthrough Treatment for Recurrent Breast Cancer

In most cases where tumors are discovered in time, patients survive five years after diagnosis. However, in about 30% of cases, breast cancer returns, sometimes even years or decades later, and the recurrence is almost always fatal. Doctors cannot provide an accurate prediction of the recurrence of breast cancer in a patient or the exact … Read more

Early Detection of Inflammatory Bowel Diseases – Groundbreaking Research from the Francis Crick Institute and Aalborg University

Early Detection of Inflammatory Bowel Diseases – Groundbreaking Research from the Francis Crick Institute and Aalborg University

Crohn’s disease and ulcerative colitis are known as inflammatory bowel diseases (IBD). These conditions are chronic, causing excessive inflammation in the intestinal tract, manifesting in symptoms such as abdominal pain and diarrhea. Identifying and treating them in the early stages is vital to improving the prognosis. Researchers from the Francis Crick Institute in London, UK, … Read more